...
机译:N-烷基 - 羟基苯甲酰苯胺羟肟酸盐作为HDAC和HSP90的双重抑制剂,下调IFN-Gamma诱导的PD-L1表达
Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;
Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;
Taipei Med Univ Coll Med Sci &
Technol PhD Program Canc Biol &
Drug Discovery Taipei Taiwan;
Taipei Med Univ Coll Med Sch Med Dept Pharmacol Taipei Taiwan;
Taipei Med Univ Coll Pharm PhD Program Clin Drug Discovery Bot Herbs Taipei Taiwan;
Taipei Med Univ Coll Pharm Grad Inst Pharmacognosy Taipei Taiwan;
Taipei Med Univ Coll Med Sci &
Technol Grad Inst Canc Mol Biol &
Drug Discovery Taipei Taiwan;
Taipei Med Univ Coll Med Sci &
Technol Grad Inst Canc Mol Biol &
Drug Discovery Taipei Taiwan;
Taipei Med Univ Coll Med Sci &
Technol Grad Inst Canc Mol Biol &
Drug Discovery Taipei Taiwan;
Taipei Med Univ Coll Pharm PhD Program Clin Drug Discovery Bot Herbs Taipei Taiwan;
Taipei Med Univ Sch Pharm Coll Pharm Taipei Taiwan;
Histone deacetylase inhibitors; Dual inhibitors; Design multiple ligand; Lung cancer; Heat shock protein; Programmed death-ligand 1 (PD-L1);
机译:N-烷基 - 羟基苯甲酰苯胺羟肟酸盐作为HDAC和HSP90的双重抑制剂,下调IFN-Gamma诱导PD-L1表达(Vol 185,111725,2020)
机译:394 POSTER异羟肟酸酯组蛋白脱乙酰基酶抑制剂通过HDAC6 / Hsp90途径选择性降解Aurora A
机译:DNA-PKCS抑制损害HDAC6介导的HSP90伴随Aurora A的伴随功能,通过增加有丝分裂的异常主轴组件来增强HDACS抑制剂诱导的细胞杀伤
机译:HDAC抑制剂Trichostatin A通过上调C / EBP-β和MKP-1的表达来抑制骨细胞发生。
机译:表观遗传靶向药物发现:甲基转移酶G9a的抑制剂和G9a和HDAC的双重抑制剂
机译:具有β-咔啉基异羟肟酸酯衍生物作为HDAC抑制剂的DNA损伤和凋亡诱导能力的研究
机译:双HDAC和PI3K抑制剂CUDC-907下调MYC并抑制MICC依赖性癌症的生长
机译:IL-1和肿瘤坏死因子-α各自上调IFN-γ受体的表达并增强人单核细胞和人单核细胞系(THp-1)上IFN-γ诱导的HLa-DR表达